Cited by 64MRI in cancer diagnosisHepatocellular Carcinoma Treatment and PrognosisMedical Imaging Techniques and Applications

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging

Open access
Thian, Yee Liang, Riddell, Angela M., Koh, Dow-Mu·2013·Cancer Imaging

Abstract

Liver-specific magnetic resonance (MR) contrast agents are increasingly used in evaluation of the liver. They are effective in detection and morphological characterization of lesions, and can be useful for evaluation of biliary tree anatomy and liver function. The typical appearances and imaging pitfalls of various tumours at MR imaging performed with these agents can be understood by the interplay of pharmacokinetics of these contrast agents and transporter expression of the tumour. This review focuses on the applications of these agents in oncological imaging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1102/1470-7330.2013.0050

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [25]Tanimoto A Higuchi N Ueno A Reduction of ringing artifacts in the arterial phase of gadoxetic acid-enhanced dynamic MR imaging Magn Reson Med Sci 2012 11 91 97 22790295

Cited by

Sorted by citations

Authors
Thian, Y. L., Riddell, A. M., & Koh, D.-M.
Affiliations
Royal Marsden NHS Foundation Trust (GB)
Corresponding author
Koh, Dow-Mu
Venue
Cancer Imaging
Publisher
E-MED LTD
Published
2013
Volume
13
Issue
4
Pages
567-579
ISSN
1470-7330 (ISSN-L)
OpenAlex
W1972276317
Cited by
64
References
91
Citations by year
2026: 5 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 9 · 2018: 2 · 2017: 6 · 2016: 3 · 2015: 12
FWCI
0.71
Type
journal article
Language
en
Open access
Locations
  • Cancer Imaging (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cancer Research UK (16464)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
liver-specific contrast agents, contrast-enhanced MRI, liver tumors, hepatocellular carcinoma, biliary tract imaging, liver function assessment, contrast agent pharmacokinetics, transporter expression, liver lesion characterization
MeSH terms
Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Contrast Media, Hemangioma, Carcinoma, Hepatocellular, Humans, Image Enhancement, Liver Neoplasms, Magnetic Resonance Imaging, Meglumine, Organometallic Compounds, Cholangiocarcinoma, Gadolinium DTPA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review